-
公开(公告)号:EP3939610A1
公开(公告)日:2022-01-19
申请号:EP20774316.2
申请日:2020-03-13
申请人: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. , Nanjing Shunxin Pharmaceutical Co., Ltd. of Chiatai Tianqing Pharmaceutical Group
发明人: WANG, Shanchun , WANG, Xunqiang , YU, Ding , LIU, Wenwen , SHU, Chao , FAN, Mengxue
IPC分类号: A61K39/395 , A61K31/4709 , A61P35/00
摘要: The present invention relates to the field of biomedicine and relates to a combined pharmaceutical composition used for treating small cell lung cancer, the composition comprising an anti-PD-L1 antibody and anlotinib, and having good anti-small cell lung cancer activity.